HMGB1 and myelodysplastic syndrome: HSCs of LR-MDS patients are more sensitive to TLR ligands (DAMP) and some of these ligands are more abundant in the BM and/or serum of MDS patients compared to healthy controls (ex HMGB1 [61], S100A8/9 [53]).